Aspira Women’s Health appoints Brian Hungerford as chief financial officer

Published 03/09/2025, 22:34
Aspira Women’s Health appoints Brian Hungerford as chief financial officer

Aspira Women’s Health Inc. (OTC QB:AWHL) announced the appointment of Brian Hungerford as chief financial officer and principal accounting officer, effective Tuesday. Hungerford replaces Julie Carrillo in these roles.

The company’s board of directors approved the appointment after entering into a Master Service Agreement and Statement of Work with Hungerford. According to the statement, Hungerford, age 50, has more than 20 years of experience across multiple industries and previously served as CFO for Kiromic Biopharma, Inc.

Under the terms of the agreement, Hungerford will receive an annual salary of $300,000, paid semi-monthly. He is also eligible for a discretionary cash bonus of up to 35% of his base salary, contingent on the achievement of performance goals set by management and the board. In addition, Hungerford will receive a stock option grant for 100,000 shares, with 25% vesting on September 2, 2026, and the remainder vesting monthly over the following 36 months.

If the agreement is terminated without cause between six and twelve months after the effective date, and certain conditions are met, Hungerford will be entitled to three months of continued base salary. If terminated without cause after twelve months, he will receive six months of continued base salary. Should his employment be terminated without cause or for good reason within a year following a change of control, all unvested stock options will vest immediately, subject to the original option term.

The company stated there are no family relationships between Hungerford and any other directors or executive officers, and no arrangements with any other party led to his appointment. Hungerford does not have any material interest in any transaction requiring disclosure.

This information is based on a press release statement included in the company’s recent filing with the Securities and Exchange Commission.

In other recent news, Aspira Women’s Health has appointed Jane Pine Wood to its board of directors. The decision was made by the company’s board of directors and announced in a statement. Ms. Wood brings extensive experience, with over 38 years as an attorney representing laboratories and healthcare providers. She is currently with McDonald Hopkins, LLC, where she has served in various capacities, including as a partner and board member. Additionally, Ms. Wood has experience as Chief Legal Counsel at BioReference Health, LLC. These developments reflect Aspira Women’s Health’s ongoing efforts to strengthen its leadership team.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.